THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

25 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

07 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

07 11月 2024 08:10:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

10 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26 8月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

08 8月 2024 08:05:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

28 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

15 5月 2024 08:05:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28 3月 2024 08:30:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

26 3月 2024 08:05:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

26 2月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

04 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

09 11月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Leadership Changes

31 10月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

31 8月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

10 8月 2023 08:10:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

25 7月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2023 Financial Results

11 5月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

29 3月 2023 08:05:00 条件 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 12月 2022 07:00:01 条件 Nasdaq GlobeNewswire